Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-09-26
1998-11-17
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3120
Patent
active
058377310
ABSTRACT:
A method of treating Huntington's Chorea by the administration of effective amounts of GLA or DGLA and a method of delaying the onset of Huntington's Chorea or preventing it altogether by administering appropriate amounts of GLA or DGLA to clinically normal individuals who are genetic carriers of the disease, and a method of preparation of medications for such purpose using such acids.
REFERENCES:
WPIDS Abstract AN 95-036098, Kyle et al, corresponding to WO 9428913, Dec. 22, 1994.
Prostaglandins, Leukotrienes and Essential 1-3 Fatty Acids (U.K.) vol. 55, No. 1-2, 1996 pp. 89-94 Vaddadi "Dyskinesias and their treatment with essential fatty acids: a review".
WPIDS Abstract AN 94-067565 (Mosh et al), corresponds to EPA 0,585,087, Mar. 2, 1994.
Chemical Abstracts AN 1988:629345, Manku et al. Jan. 1988.
MacMillan Keith D.
Scotia Holdings PLC
LandOfFree
Fatty acid treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fatty acid treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fatty acid treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-884809